Rafa Laboratories to acquire a significant stake in ExCEEd Orphan and expand its international capabilities in medicines addressing rare diseases
Jerusalem, Israel and Prague, Czech Republic, August 1st, 2022. Rafa Laboratories LTD. (“Rafa”)
ExCEEd Orphan announces new member of the EO Management team
ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in
ExCEEd Orphan announces partnership with Amryt to exclusively distribute Filsuvez® in Central and Eastern Europe (CEE)
Under the terms of the agreement, ExCEEd Orphan will have exclusive rights to
ExCEEd Orphan announces partnership with SERB to exclusively distribute Voraxaze® and DigiFab® in Central and Eastern Europe (CEE)
Under the terms of the agreement, ExCEEd Orphan will have exclusive rights to
ExCEEd Orphan announces opening of the third non-EU affiliate in Albania
The ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions
ExCEEd Orphan announces partnership with Proveca Pharma Ltd to commercialise and distribute Sialanar® exclusively in Central and Eastern Europe (CEE)
Under the terms of the agreement, ExCEEd Orphan will have exclusive rights to
First sales of ProPrems in the CEE region
„ExCEEd Orphan and Neobiomics are happy to announce the first sales of ProPrems®
ExCEEd Orphan announces new members of the team in Adriatic Region
ExCEEd Orphan s.r.o., a Czech based multinational company providing full business solutions in
ExCEEd Orphan announces signature of an exclusive Distribution Agreement with Advicenne for marketing and distribution of Sibnayal® in Central and Eastern Europe
ExCEEd Orphan Distribution d.o.o., a Croatia based fully-owned subsidiary of ExCEEd Orphan s.r.o.,